HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J S Malik Peiris Selected Research

Nucleocapsid Proteins

11/2020Characterization of SARS-CoV-2 N protein reveals multiple functional consequences of the C-terminal domain.
7/2005Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia.
12/2004False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide.
7/2004Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in sars patients by enzyme-linked immunosorbent assay.
7/2004Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus.
5/2004Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J S Malik Peiris Research Topics

Disease

49Human Influenza (Influenza)
01/2021 - 12/2005
47Infections
01/2022 - 05/2003
18Influenza in Birds (Avian Flu)
01/2019 - 04/2006
11Severe Acute Respiratory Syndrome
06/2007 - 10/2003
8COVID-19
01/2022 - 07/2020
7Virus Diseases (Viral Diseases)
09/2014 - 08/2002
6Pneumonia (Pneumonitis)
06/2014 - 05/2004
3Acute Lung Injury
03/2016 - 04/2008
3Cough
01/2014 - 06/2004
2Inflammation (Inflammations)
01/2022 - 06/2007
2Vaccinia
04/2014 - 03/2009
2Fever (Fevers)
01/2014 - 06/2004
1Herpesviridae Infections (Herpesvirus Infection)
10/2020
1Pulmonary Edema
01/2019
1Parkinson Disease (Parkinson's Disease)
01/2018
1Lung Diseases (Lung Disease)
03/2016
1Cytokine Release Syndrome
01/2016
1Body Weight (Weight, Body)
09/2014
1Coinfection
01/2014
1Diarrhea
11/2012
1Dengue (Dengue Fever)
01/2012
1Orthomyxoviridae Infections
11/2011
1Osteoporosis
07/2011
1Heart Diseases (Heart Disease)
07/2009
1Smallpox (Variola)
03/2009
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2009
1Lung Injury
04/2008

Drug/Important Bio-Agent (IBA)

21VaccinesIBA
01/2022 - 03/2009
18CytokinesIBA
01/2022 - 08/2005
13Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2010
13AntibodiesIBA
01/2022 - 05/2004
13Influenza Vaccines (Influenza Vaccine)FDA Link
01/2021 - 03/2009
11Antiviral Agents (Antivirals)IBA
01/2018 - 12/2005
10ChemokinesIBA
11/2018 - 08/2005
7ImmunosorbentsIBA
07/2005 - 05/2004
7EnzymesIBA
07/2005 - 05/2004
6Monoclonal AntibodiesIBA
04/2021 - 01/2009
6Nucleocapsid ProteinsIBA
11/2020 - 05/2004
6EpitopesIBA
10/2019 - 01/2009
5AntigensIBA
10/2020 - 07/2005
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2009 - 04/2006
4Immunoglobulin G (IgG)IBA
07/2005 - 05/2004
3Hemagglutinins (Hemagglutinin)IBA
10/2019 - 05/2010
3Viral RNAIBA
01/2017 - 10/2006
3Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
01/2012 - 05/2005
3Neuraminidase (Sialidase)IBA
09/2010 - 12/2005
3Immunoglobulin M (IgM)IBA
07/2005 - 05/2004
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2020 - 05/2003
2Amantadine (Aman)FDA LinkGeneric
01/2018 - 06/2006
2Oseltamivir (Tamiflu)FDA Link
01/2018 - 12/2005
2Interleukin-15 (Interleukin 15)IBA
04/2014 - 03/2009
2AerosolsIBA
01/2014 - 01/2014
2Biological ProductsIBA
01/2014 - 11/2011
2RNA (Ribonucleic Acid)IBA
01/2014 - 01/2005
2Neutralizing AntibodiesIBA
01/2014 - 01/2012
2Interferon-gamma (Interferon, gamma)IBA
10/2011 - 05/2006
2Pharmaceutical PreparationsIBA
07/2011 - 05/2008
2Interferon Type IIBA
11/2010 - 12/2009
2oplunofuspIBA
02/2010 - 09/2009
2Peptides (Polypeptides)IBA
07/2005 - 12/2004
2Immunoglobulin A (IgA)IBA
07/2004 - 05/2004
1Interleukin-6 (Interleukin 6)IBA
01/2022
1Interleukin-8 (Interleukin 8)IBA
01/2022
1Viral ProteinsIBA
11/2020
1Protein CIBA
11/2020
1LuciferasesIBA
10/2020
1NADPH Oxidases (NAD(P)H oxidase)IBA
06/2020
1Edetic Acid (EDTA)FDA Link
01/2020
1Toll-Like Receptor 3IBA
09/2014
1Toll-Like Receptors (Toll-Like Receptor)IBA
09/2014
1indirubinIBA
06/2014
1Toll-Like Receptor 10IBA
03/2014
1InterferonsIBA
03/2014
1Aerosolized Particles and DropletsIBA
01/2014
1Polytetrafluoroethylene (Teflon)FDA Link
01/2014
1Therapeutic UsesIBA
06/2013
1Nucleic AcidsIBA
11/2012
1Formaldehyde (Formol)FDA Link
02/2012
1paraform (paraformaldehyde)IBA
02/2012
1NucleoproteinsIBA
02/2012
1PronaseIBA
02/2012
1Glycoproteins (Glycoprotein)IBA
01/2012
1Cysteine Proteases (Cysteine Protease)IBA
10/2011
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2011
1Chemokine ReceptorsIBA
10/2011
1isopentenyl pyrophosphate (isopentenyl diphosphate)IBA
10/2011
1indolepropanol phosphate (IPP)IBA
10/2011
1Pamidronate (Aredia)FDA LinkGeneric
07/2011
1Interleukin-2 (IL2)IBA
05/2010
1Interferon-betaIBA
01/2010
1Broadly Neutralizing AntibodiesIBA
11/2009
1OzoneIBA
02/2009
1Environmental Pollutants (Pollutants, Environmental)IBA
02/2009
1Air Pollutants (Pollutants, Air)IBA
02/2009
1Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA
01/2009
1Immune Sera (Antisera)IBA
01/2009
1oxidized- L- alpha- 1- palmitoyl- 2- arachidonoyl- sn- glycero- 3- phosphorylcholineIBA
04/2008

Therapy/Procedure

8Therapeutics
04/2021 - 12/2005
3Hand Hygiene
01/2014 - 05/2008
2Critical Care (Surgical Intensive Care)
04/2021 - 07/2020